Main Subject - Business

You can’t build a reputation on what you are "going" to d

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

o.

Henry Ford

Everyone procrastinates

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

in their own way. For some, procrastination results from the

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

belief that there is always one more bit of information that

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

will really make the case?or, conversely, really undo the ca

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

se. They resist taking action for fear that they’ve missed so

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

mething vital. They become paralyzed by data gathering, repor

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

ting and endless analysis.

On the other hand, there are th

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

e visionaries. They dream grand dreams and put shape to what

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

had been unformed potential. But this is exciting work and th

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

mundane bricks and mortar of bringing dreams to reality lack

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

s the same zest. They procrastinate because the next dream i

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

s so alluring that they simply don’t want to stop until they’

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ve captured the whole thing.

Of course, stalling for facts

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

or for dreams brings the same result—nothing. We can’t begin

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

to imagine what the world would look like if all the good id

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

eas people have had were brought to fruition instead of being

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

thought about, talked over, analyzed or just generally kicke

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

d around.

Don’t succumb. Build your reputation around what

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

you’ve done not what you’d like to do.

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/24808/mainsubjects-A-Journey-of-a-Thousand-Miles.html">A Journey of a Thousand Miles</a>

BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/24808/mainsubjects-A-Journey-of-a-Thousand-Miles.html]A Journey of a Thousand Miles[/url]

Does your nonprofit's name say everything it could? NOW Legal Defense & Education Fund had a 34-year history of positive action, but their target audiences were still confused by their name. In response, the organization’s leadership focused on a name change as the communications strategy most likely to boost its ongoing evolution and outreach to broader audiences. Vice President of Communications, Maureen McFadden details the process that led to the organization’s ultimate success and provides proven tips for any nonprofit considering a name change.

A job is not just “what we do.” In many ways it’s who we are. Much of our life is defined by how we make a living.

Many new entrepreneurs do not understand the difference between selling and marketing. In mature businesses, sales and marketing departments often are competitive with each other. The marketing department creates advertising, sales promotion, sales collateral, display and branding strategies applicable to a product. The sales team is charged with utilizing the tools created by the marketing department and executing the strategy to generate sales turnover.

Tags

Links

Main Subject - A Journey of a Thousand Miles

Related Articles: